George Church-founded biotech raises $125M to transplant pig organs into humans

Cambridge startup eGenesis, co-founded in 2015 by genomics pioneer George Church, has raised $125 million in a Series C round as it prepares for an ambitious next step: transplanting its genetically edited pig organs into humans.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.